Olostajeng 10/5 milligrams (Olmesartan Medoxomil, Rosuvastatin)

Adult dose

Olmesartan Medoxomil: The recommended initial dose is 10 mg once daily, regardless of meal timing. If blood pressure is not adequately controlled, it can be increased to 20 mg once daily, with a maximum increase to 40 mg. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with maximum effect observed after approximately 8 weeks. Rosuvastatin: The initial dose is 5 mg once daily, and the maintenance dose is once daily.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, therefore it should be immediately discontinued upon confirmation of pregnancy. Women with hypersensitivity to this medication, pregnant or breastfeeding women, and fertile women not utilizing adequate contraceptive methods should not take this medication. Patients with very poor kidney function, those on dialysis, severe liver disease, bile duct obstruction, and those with certain liver diseases or muscle disorders should refrain from taking this medication. This medication contains lactose, and should not be administered to patients with lactose intolerance or related genetic issues. Patients with low blood pressure or decreased blood volume, those with impaired kidney function, and those at risk of hyperkalemia require special caution and regular monitoring of blood pressure, kidney function, and potassium levels when administering this medication. Dizziness may occur during the use of this medication, thus caution should be exercised when driving or operating dangerous machinery. Patients with a history of liver disease or those consuming alcohol excessively should undergo regular liver function tests before and during treatment with this medication. If symptoms of myalgia, muscle weakness, or cramps occur, they should be reported to a physician immediately, and muscle enzyme levels should be tested, with discontinuation if severe. This medication may interact with other drugs, so it's essential to inform the physician or pharmacist of any other medications being taken. Pregnant or planning to become pregnant women must consult a physician before taking this medication and should avoid it during pregnancy. Breastfeeding women should also consult a physician regarding the effects on the baby before deciding to take this medication. Safety and efficacy in pediatric patients under 18 years of age have not been established, so its use is not recommended. Elderly patients may have decreased bodily metabolism, thus dosage adjustments and caution are needed. In cases of overdose, symptoms such as hypotension and palpitations may occur, and immediate medical attention should be sought. This medication should be stored out of reach of children, and should not be transferred to other containers.

Serious side effects

• Hives
• angioedema
• anaphylactic reaction
• multiple organ failure syndrome
• viral pneumonia
• angioedema
• intestinal vascular edema
• rhabdomyolysis
• hyperkalemia
• acute renal failure

Mild side effects

• Headache
• dizziness
• decreased perception
• drowsiness
• gastroesophageal reflux
• constipation
• dental caries
• dyspepsia
• gastric ulcers
• gastritis

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance

Pale yellow round film-coated tablets

Package unit

30 tablets ((10 tablets/PTP) x 3), 30 tablets/bottle